Skip to content
healthcare.dev
Get a free key

Guaifenesin and Pseudoephedrine HCl

NDC 51660-074, Guaifenesin and Pseudoephedrine HCl, tablet, extended release, from Ohm Laboratories, Inc..

Product NDC
51660-074
Status
Listed
Labeler
Ohm Laboratories, Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA212542
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51660-074 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1
  • PSEUDOEPHEDRINE HYDROCHLORIDE60 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
51660-074-18516600074181 BLISTER PACK in 1 CARTON (51660-074-18) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 51660-074 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51660-074 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51660-074. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.